Synthesis of the N‐methyl Derivatives of 2‐Aminothiazol‐4(5H)‐one and Their Interactions with 11βHSD1‐Molecular Modeling and in Vitro Studies
- 23 April 2019
- journal article
- research article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 16 (6) , e1900065
Abstract
11β‐Hydroxysteroid dehydrogenase type 1 (11β‐HSD1) is an enzyme that affects the body's cortisol levels. The inhibition of its activity can be used in the treatment of Cushing's syndrome, metabolic syndrome and type 2 diabetes. In this study, we synthesized new derivatives of 2‐(methylamino)thiazol‐4(5H)‐one and tested their activity towards inhibition of 11β‐HSD1 and its isoform – 11β‐HSD2. The results were compared with the previously tested allyl derivatives. We found out that methyl derivatives are weaker inhibitors of 11β‐HSD1 in comparison to their allyl analogs. Due to significant differences in the activity of the compounds, molecular modeling was performed, which was aimed at comparing the interactions between 11β‐HSD1 and ligands differing by substituent at the amine group (allyl vs. methyl). Modeling showed that the absence of the allyl group can lead to the rotation of whole ligand molecule which affects its interaction with the enzyme.Keywords
This publication has 25 references indexed in Scilit:
- A novel derivatives of thiazol-4(5H)-one and their activity in the inhibition of 11β-hydroxysteroid dehydrogenase type 1Bioorganic Chemistry, 2018
- Cushing's syndrome: epidemiology and developments in disease managementClinical Epidemiology, 2015
- Synthesis of 2-{2-[(α/β-naphthalen-1-ylsulfonyl)amino]-1,3-thiazol-4-yl} acetamides with 11β-hydroxysteroid dehydrogenase inhibition and in combo antidiabetic activitiesEuropean Journal of Medicinal Chemistry, 2014
- 11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular DiseaseDrugs, 2013
- 1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ß-HSD1 inhibitors for the treatment of diabetesBioorganic & Medicinal Chemistry Letters, 2013
- Metabolic syndrome: definitions and controversiesBMC Medicine, 2011
- The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- 2-(S)-Phenethylaminothiazolones as Potent, Orally Efficacious Inhibitors of 11β-Hydroxysteriod Dehydrogenase Type 1Journal of Medicinal Chemistry, 2007
- Effects of the 11β-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2003
- Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1Journal of Medicinal Chemistry, 2002